Although the Covid-19 pandemic may not be over, it appears to have entered its concluding phase.
Sales of Covid-19 vaccines, as well as therapies, are falling sharply, as are the share prices of their producers. But what are we left with? And what other opportunities are open to the mRNA vaccine technology that performed so powerfully during the pandemic? And how can it be improved?
Suggestion box (Suggestions on future episodes, points for clarification, comments, etc.)
Subscribe (Get notified when new episodes are available. NO marketing!)
Disclaimer
Ready to create your own impactful podcast series?
Contact us at elearningbytes.co.uk to get started!
